Nikolai Loft

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Alexander Egeberg, Nana Aviaaja Lippert Rosenø, David Thein et al. · Seminars in Arthritis and Rheumatism · 2022 · 84 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Associations between functional polymorphisms and response to biological treatment in Danish patients with psoriasis

Nikolai Loft, Lone Skov, Lars Iversen et al. · The Pharmacogenomics Journal · 2017 · 62 citations · Full text

Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis

Anne‐Sofie Halling, Maria Rasmussen Rinnov, Iben Frier Ruge et al. · Journal of Allergy and Clinical Immunology · 2022 · 57 citations · Full text

Prevalence and characterization of treatment‐refractory psoriasis and super‐responders to biologic treatment: a nationwide study

Nikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 47 citations · Full text

Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis

Nikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen et al. · JAMA Dermatology · 2021 · 46 citations · Full text